drugset / Trial / NCT05628584

High FODMAP Diet With Metformin in preDM

NCT05628584 ↗

RandomizedCrossoverDouble-blindPrevention

Summary

This is a prospective, double blinded, randomised cross over feeding trial examine high or low FODMAP diet in combination with metformin on postprandial glucose responses and gastrointestinal tolerability and gut microbiota profiles. The trial will compare high or low FODMAP diet, each of 10 days duration in combination with 5 days metformin, separated by a washout period of at least 2 weeks.

Timeline

Start
2022-11-11
Primary completion
2023-08-25
Completion
2023-10-15

Drugs

EvaluationDrugModalityDoseRoute
Background Metformin Small molecule 1000 mg —